Sign up today and take advantage of member-only content — the kind of timely, cutting edge industry insight that only Money Management Executive can deliver.
  • Exclusive Online Only Content
  • Free Daily Email News Alerts
  • Asset Management Blogs
Pharmaceutical and biotech acquisitions are down 13% from a year earlier. (Bloomberg News)

Biotech M&A Falls Off as Trump Dashes Hopes of a New Pharma Boom


So far this year, 1.2 million shares were traded daily on average on the Nasdaq Biotechnology ETF, down from 2.2 million in the same period in 2014.

The full article is available to Money Management Executive subscribers only

SUBSCRIBE NOW!
Free Trial

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.